| Description |
339 pages ; 25 cm. |
| Series |
The Luther H. Hodges Jr. and Luther H. Hodges Sr. series on business, entrepreneurship, and public policy |
|
Luther H. Hodges, Jr. and Luther H. Hodges, Sr. series on business, entrepreneurship, and public policy.
|
| Bibliography |
Includes bibliographical references and index. |
| Summary |
"The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these past successes--and indeed because of them--our ability to deliver new medicines may be quickly coming to an end. Moving from the twentieth century to the present, this book reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy"-- Provided by publisher. |
| Contents |
Why regulate medicines? -- Trials and tribulations -- Dreams of greatness : the birth of the pharmaceutical industry -- Triumph and tragedy -- Ivory tower of power -- The DNA of biotechnology -- Blockbusters and bombs : pressures on the pharmaceutical industry -- Sea monsters, immunauts, and death panels -- Drama on the I-270 tech corridor -- Autophagy -- Three views of a train wreck -- Bridging the valley. |
| Subject |
Drug development.
|
|
Drugs -- Research -- Economic aspects.
|
|
Pharmaceutical industry.
|
|
Drug development. (OCoLC)fst00898670
|
|
Drugs -- Research -- Economic aspects.
(OCoLC)fst00898899
|
|
Pharmaceutical industry. (OCoLC)fst01060129
|
| ISBN |
9781469630625 (cloth) (alkaline paper) |
|
1469630621 (cloth) (alkaline paper) |
|
9781469630632 (ebook) |
|
